T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

Investment analysts at StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Friday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Down 16.8 %

Shares of TTOO stock opened at $0.07 on Friday. The stock’s fifty day simple moving average is $0.32 and its 200 day simple moving average is $1.48. T2 Biosystems has a one year low of $0.06 and a one year high of $6.95.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.